U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: February 28 - March 6, 2021
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: February 28 - March 6, 2021

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 03/01/2021
Location: Virtual
Subject: COVID-19 Testing Update
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several stakeholders from health care, patient advocacy organizations, hospitals, pharmacies, academia, state public health laboratories, and industry

Event Date: 03/01/2021
Location: Virtual
Subject: COVID-19 Vaccines and Emergency Use Authorizations Process
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Governors, state officials, and state policy staff

Event Date: 03/04/2021
Location: Virtual
Subject: Vaccine Town Hall
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Adult Vaccine Access Coalition, United Farm Workers Union, and government

Event Date: 03/05/2021
Location: Virtual
Subject: FDA Rare Disease Day 2021
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, media, government and other registered guests

Official Name: Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner

Event Date: 03/04/2021
Location: Virtual
Subject: COVID-19 Evidence Accelerator Diagnostics Lab Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, and other stakeholders

Official Name: Erika Anderson, Acting Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 03/03/2021
Location: Virtual
Subject: University of Georgia's Center of Food Safety Conference
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members from across the food industry, academia, and government

Event Date: 03/03/2021
Location: Virtual
Subject: Leafy Greens Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several executives from from across the food retail industry, to include Wegmans, Walmart, Kroger, and Yum Brands

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 03/03/2021
Location: Virtual
Subject: Implementation of Mutual Agreement
FDA Participant/Group: N/A
Non FDA Participant/Group: Andrzej Rys (Health and Food Safety, European Commission);

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

Event Date: 03/01/2021
Location: Virtual
Subject: Biomarkers Consortium Executive Committee Meeting
FDA Participant/Group: PATRIZIA CAVAZZONI; VASUM PEIRIS;
Non FDA Participant/Group: Representatives from government, industry, academia, patient advocacy, and other not for profit organizations

Event Date: 03/01/2021
Location: Virtual
Subject: Rx to OTC Switch Policy & Procedural Meeting
FDA Participant/Group: JACQUELINE CORRIGAN CURAY; BRYON PEARSALL; PATRIZIA CAVAZZONI;
Non FDA Participant/Group: Mary Anne Dunlap, Mike Bailey, Paul Hudson (Sanofi);

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 03/01/2021
Location: Virtual
Subject: Johns Hopkins Bloomberg School of Public Health Spotlight Series; Speaker: In Record Time: COVID-19 Vaccines and FDA Expedited Timelines
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia and industry

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 03/04/2021
Location: Virtual
Subject: Updates on Cosmetic Reform Legislation
FDA Participant/Group: LAURA PILLSBURY; STEVEN MUSSER; LINDA KATZ;
Non FDA Participant/Group: Industry, government, and other stakeholders

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 03/05/2021
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: MARLA KELLER; TRACEY FORFA; DAVID EDWARDS; JENNIFER ERICKSON; JEANETTE MURPHY; SIOBHAN DELANCEY; CINDY BURNSTEEL; ANNE NORRIS; CHARLOTTE CONWAY;
Non FDA Participant/Group: Representatives from the American Feed Industry Association

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Acting Chief Counsel

No Significant Event

 

Back to Top